File: '\\swfile\EmailIn\20240405 170444 Attachment MUSL - NR re_ Berk Debt Settlement, Benaterra, Elementary (April 5).docx'

PROMINO NUTRITIONAL SCIENCES PROVIDES CORPORATE UPDATE

BURLINGTON, ON, April 5, 2024 /CNW/ - Promino Nutritional Sciences Inc. (CSE: MUSL) (OTC: MUSLF) (FRANKFURT:93X) (the "Company" or "Promino") announces it has entered into consulting agreements with a capital markets advisory consultant ("Fiscal Consultant") and a marketing consultant ("Marketing Consultant") to provide certain consulting services to the Company for initial terms of 12 months and 18 months, respectively. In consideration for the services provided to the Company by the consultants, the Company has agreed to issue an aggregate of 200,000 common shares to the Fiscal Consultant, and issue an aggregate of 1,000,000 common shares and pay $70,000 to the Marketing Consultant. All shares issuable to the consultants are to be issued in staggered tranches in accordance with the terms of their respective consulting agreements. The consultants are arm's-length to the Company.

The Company also announces it has agreed to settle an aggregate of $25,000 of outstanding indebtedness owing to an arm's-length creditor (the "Creditor") in exchange for the issuance of an aggregate of 166,667 common shares of the Company to the Creditor (the "Debt Settlement"). Completion of the Debt Settlement is subject to acceptance by the Canadian Securities Exchange.

Any shares issued to the consultants or in connection with the Debt Settlement will be subject to a statutory hold period of four months and one day.

About Promino

Promino is an innovative and research driven Canadian nutraceutical company specializing in the development of patented and science-based products for the global consumer packaged goods market, with a portfolio focused specifically on muscle health. Promino's lead product, Rejuvenate(TM), is a patented proprietary formulation that is clinically proven to assist in the building, rebuilding, restoration and rejuvenation of natural muscle mass. Promino also offers Promino(TM), an elite performance supplement for both professional and amateur athletes to accelerate muscle recovery, build strength and accelerate recovery from injury. Promino was founded in 2015 and is located in Burlington, Ontario.

To learn more about Promino, visit http://www.drinkpromino.com

More information about Rejuvenate(TM) can be found https://www.rejuvenatemuscle.com

Forward-Looking Statements

This news release contains "forward-looking information" and "forward-looking statements" (collectively, "forward-looking statements") within the meaning of applicable Canadian securities legislation. All statements, other than statements of historical fact, are forward-looking statements and are based on expectations, estimates and projections as at the date of this news release. All statements that address activities, events, or developments that the Company expects or anticipates will, or may, occur in the future, are forward-looking statements, including statements regarding: the Debt Settlement, including the timing, terms and receipt of all regulatory approvals for the Debt Settlement; and the Company's business prospects, future trends, plans and strategies. In some cases, forward looking statements are preceded by, followed by, or include words such as "may", "will," "would", "could", "should", "believes", "estimates", "projects", "potential", "expects", "plans", "anticipates", "continues", or the negative of those words or other similar or comparable words. In preparing the forward-looking statements in this news release, the Company has applied several material assumptions, including, but not limited to, the Company will receive all regulatory approvals necessary for the Debt Settlement in a timely fashion, that protein supplement market growth will continue as anticipated by the Company, and that general business and economic conditions will not change in a materially adverse manner. These forward-looking statements are based on reasonable assumptions and estimates of management of the Company at the time such statements were made. Actual future results may differ materially as forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the Company to materially differ from any future results, performance or achievements expressed or implied by such forward-looking statements. Although the forward-looking statements contained in this news release are based upon what management of the Company believes, or believed at the time, to be reasonable assumptions, the Company cannot assure shareholders that actual results will be consistent with such forward-looking statements, as there may be other factors that cause results not to be as anticipated, estimated or intended. Readers should not place undue reliance on the forward-looking statements and information contained in this news release. The Company assumes no obligation to update the forward-looking statements of beliefs, opinions, projections, or other factors.

No stock exchange, securities commission or other regulatory authority has approved or disapproved the information contained herein.

SOURCE Promino Nutritional Sciences Inc.

For further information:

Vito Sanzone, Chief Executive Officer, ir@elementnutrition.com, 289-348-1970 ext. 222;

Marc Charbin, Investor Relations, ir@elementnutrition.com, 416-467-5229